Afinion 2
Payments companies reported to CMS as associated with Afinion 2. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Afinion 2, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Afinion 2
These are the largest totals companies reported as associated with Afinion 2. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Olugbemiga Jegede | Greensboro, NC | Internal Medicine | $19,216.93 |
| Vivian Fonseca | New Orleans, LA | Endocrinology, Diabetes & Metabolism | $9,325.00 |
| Aaron King | San Antonio, TX | Family Medicine | $7,794.18 |
| Michael Kobernick | Warren, MI | Emergency Medicine | $6,820.36 |
| Michael Fine | Laguna Beach, CA | $5,698.47 | |
| Eugene Wright | Fayetteville, NC | Internal Medicine | $4,750.00 |
| Eden Miller | Bend, OR | Family Medicine | $3,242.91 |
| Timothy Bailey | Escondido, CA | Endocrinology, Diabetes & Metabolism | $3,150.00 |
| Neil Skolnik | Jenkintown, PA | Family Medicine | $2,675.00 |
| Pamela Kushner | Los Angeles, CA | Family Medicine | $2,275.00 |
Prescribed Afinion 2?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.